A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
- Lin, C.-C.
- Garralda, E.
- Schöffski, P.
- Hong, D.S.
- Siu, L.L.
- Martin, M.
- Maur, M.
- Hui, R.
- Soo, R.A.
- Chiu, J.
- Zhang, T.
- Ma, B.
- Kyi, C.
- Tan, D.S.W.
- Cassier, P.A.
- Sarantopoulos, J.
- Weickhardt, A.
- Carvajal, R.D.
- Spratlin, J.
- Esaki, T.
- Rolland, F.
- Akerley, W.
- Deschler-Baier, B.
- Rispoli, L.
- Samant, T.S.
- Chowdhury, N.R.
- Gusenleitner, D.
- Kwak, E.L.
- Askoxylakis, V.
- De Braud, F.
- Show all authors +
ISSN: 2162-402X, 2162-4011
Year of publication: 2024
Volume: 13
Issue: 1
Type: Article